BSE · ANG
ANG Lifesciences India Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#3,349
of 5,004 stocks
🏆 New peak
▲ 861W
Peak #3,349 · 01 Oct 2026
A microcap name in Healthcare, ANG Lifesciences India Limited trades at an undemanding earnings multiple, has a subdued return on equity, and remains firmly promoter-controlled, with promoters holding 71%.
Market Cap
53.54 Cr
P/E Ratio
4.86
P/B Ratio
1.01
ROE
-20.96%
ROCE
-8.47%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 15.30 Cr | 23.50 Cr | 18.73 Cr | 26.05 Cr |
| Net Profit | -4.24 Cr | -1.38 Cr | -4.75 Cr | -2.95 Cr |
| EPS | 3.24 | 1.07 | 3.60 | 2.24 |
| Operating Profit | -3.34 Cr | 1.07 Cr | -4.04 Cr | -1.32 Cr |
Shareholding pattern
Promoter
70.60%
Public
29.40%
PUBLIC BREAKDOWN
Individuals
28.10%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 13 Jul 2022 | Bonus | Bonus issue 1:4 |
| 02 Nov 2021 | Dividend | Interim Dividend - Rs. - 1.0000 |
| 22 Sep 2021 | Bonus | Bonus issue 1:1 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.